← Browse by Condition
Medical Condition

ulcerative colitis uc

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for ulcerative colitis uc sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — ulcerative colitis uc Clinical Trials

How many clinical trials are currently recruiting for ulcerative colitis uc?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for ulcerative colitis uc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ulcerative colitis uc?
ulcerative colitis uc research spans Phase 2 (4 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ulcerative colitis uc clinical trial?
Eligibility criteria for ulcerative colitis uc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
4
Phase 3
1
Top Sponsors
Bristol-Myers Squibb 1 trial
McMaster University 1 trial
Dalia Lartey 1 trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1 trial
Assistance Publique - Hôpitaux de Paris 1 trial

Recruiting Clinical Trials

NCT07271069
Recruiting

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

Enrollment
150 pts
Location
Japan
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06773182
Recruiting

Assessing Interventions of Diet in IBD

Enrollment
45 pts
Location
Canada
Sponsor
McMaster University
View Trial →
NCT06604260 Phase 2
Recruiting

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

Enrollment
20 pts
Location
Netherlands
Sponsor
Dalia Lartey
View Trial →
NCT06604273 Phase 2, Phase 3
Recruiting

Unravelling Intestinal Fibrosis in Ulcerative Colitis

Enrollment
10 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
View Trial →
NCT07300553 Phase 2
Recruiting

Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease

Enrollment
45 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT07427017 Phase 2
Recruiting

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Enrollment
180 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT06723418
Recruiting

Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)

Enrollment
2,000 pts
Location
Austria, Croatia, Ge...
Sponsor
University of Glasgow
View Trial →
NCT06962020
Recruiting

Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis

Enrollment
400 pts
Location
China
Sponsor
Xijing Hospital of Digestive D...
View Trial →
NCT07524244
Recruiting

Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

Enrollment
160 pts
Location
United States
Sponsor
Fuller Research Foundation
View Trial →
NCT06862843
Recruiting

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.

Enrollment
90 pts
Location
Italy
Sponsor
Meyer Children's Hospital IRCC...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology